Free tool
FDA Clearance Tracker
Last checked: Nov 19, 2026Latest source record: Nov 8, 2026 (newest decision)openFDA last updated: Nov 9, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Product code QGL: Transcutaneous Nerve Stimulator For Adhd. Open this device type's page
5 decisions
product code QGL. Showing 1 to 5, newest first. PMA results are original approvals and panel-track supplements.
- ADDNOX (BPSPM1)510(k)
K243289 · Decided Jan 16, 2025 · 90 days after receipt
Device type: Transcutaneous Nerve Stimulator For Adhd (QGL) · Neurology & Neurosurgery
- BT-1000510(k)
K232991 · Decided Aug 28, 2024 · 341 days after receipt
Device type: Transcutaneous Nerve Stimulator For Adhd (QGL) · Neurology & Neurosurgery
K233293 · Decided Jan 16, 2024 · 109 days after receipt
Device type: Transcutaneous Nerve Stimulator For Adhd (QGL) · Neurology & Neurosurgery
- SMILE510(k)
K213629 · Decided Feb 12, 2023 · 452 days after receipt
Device type: Transcutaneous Nerve Stimulator For Adhd (QGL) · Neurology & Neurosurgery
- Monarch eTNS SystemNew device typeDe Novo
DEN180041 · Decided Apr 19, 2019 · 263 days after receipt
Device type: Transcutaneous Nerve Stimulator For Adhd (QGL) · Neurology & Neurosurgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.